Newsroom / CNA
In the last 14 days (11-24 October), 1,374 cases of coronavirus were diagnosed in Cyprus, which corresponds to 40.5% of the total cases (3,388) recorded until the October 24, according data published in the National Surveillance Report on Thursday, produced by the Epidemiological Surveillance Unit of the Ministry of Health.
The Report states that as of October 24, a total of 3,388 COVID-19 cases and 32 deaths have been reported in the Republic of Cyprus. The 14-day cumulative notification rate is 158.1 per 100,000 population.
In the last 14 days (11-24 October), 1,374 cases were diagnosed. The median age of cases is 32 years, while 51.7% are male. In terms of place of exposure, 7.4% were imported, 89.5% were locally-acquired, and for 3.1% place of exposure is unknown.
During the course of those two weeks, 33 people were hospitalised, of a median age of 58 years and 57.6% were male. Among cases hospitalised, two were in intensive care units (ICU) and intubated. The mean age of ICU patients is 68 years, and both are male.
A total of 461,136 tests had been performed by October 24th (52,647.1 per 100,000 population). In particular, over the last 14 days 50,719 tests have been performed (5,790.5per 100,000 population).
Among 1,374 cases diagnosed since October 11, 52% are male and 48% female. By age group, cases include 170 infants, children and adolescents aged 0-17years-old (12%), 1,086 adults aged 18-59 years (79%), 117 persons aged 60 years and older (9%), and for one case information was missing. The median age of all cases diagnosed in the last 14 days is 32 years.
Among all cases diagnosed in the last 14 days, 794 (57.8%) were reported in Limassol district, 222 (16.2%) in Paphos, 149 (10.8%) in Nicosia, 117 (8.5%) in Larnaca, 36 (2.6%) in Famagusta, and 56 (4.1%) were reported either in the British bases or had a residence abroad, or information was not available.
In the last 14 days (11-24 October), of 1,374 cases sampled and notified, 7.4% were imported, 89.5% were locally-acquired, and 3.1% are unknown.
As regards the clinical features of the 1,374 laboratory-confirmed COVID-19-cases, clinical information is available for 99.1% (n = 1,362), of which 27.4% (n = 373) reported no symptoms at diagnosis and 72.6% (n = 989) reported at least one symptom. Information on comorbidities was available for 1,335 (97.1%) cases. Of these, 309 (23.2%) reported at least one comorbidity.
As of October 24, 32 deaths were reported in Cyprus (Case Fatality Risk-CFR: 0.9%). The mortality for COVID-19 is 3.7 per 100,000 population. Twenty-three deaths (71.9%) involved men and nine (28.1%) women; the median age of all deaths was 76 years (IQR: 67-79 years).
Twelve deaths were reported among residents in Larnaca, eight in Paphos, five in Nicosia, four in Limassol, and three in Famagusta. The median time from date of sampling to death was 11.5 days (IQR: 5-29.5 days). For 25 deaths, COVID-19 was the underlying cause of death (COVID-19 CFR: 0.7%). Over the last 14 days no deaths were reported (mortality for COVID-19: 0 per 100,000 population).
In total, 8.6% (n = 292) of people with COVID-19 received hospital care, by October 24.The median age of hospitalized patients was 59 years (IQR: 47-72 years). Hospitalized cases were mainly males (n = 169; 61.3%).The median age of patients still hospitalised (n = 33) is 58 years (IQR: 52-72 years) and 57.6% are male.
Overall, 36 cases (12.3% of all hospitalized patients) have been admitted to ICU. The median age of patients ever admitted to ICU was 65.5 years (IQR: 57-75years). ICU patients are mainly male (n = 27; 75%).The overall median length of stay in ICU (for all 36 ICU cases) was 13.5 days (IQR: 8-29 days).
According to the Report, as of October 24, two cases were still in ICU. The mean age of ICU patients is 68 years and both are males. The number of cases currently in ICU is 0.2 per 100,000 population. Overall, a total of 31 ICU patients (86.1% of all ICU patients) have been intubated.
By October 24, among cases alive, 47.2% (n = 1,583) of COVID-19 cases have recovered, of which 1,091 (68.9%) tested negative two consecutive times, and 492 (31.1%) have been released as per the new guidelines.
The median time between the second negative result and the first date of sampling was 21 days.
